Your session is about to expire
← Back to Search
Trazodone vs Quetiapine for ICU Delirium (TraQ Trial)
TraQ Trial Summary
This trial is looking at whether trazodone is better than quetiapine or a placebo at managing ICU delirium in adult surgical ICU patients.
TraQ Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTraQ Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TraQ Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently experiencing severe withdrawal symptoms from alcohol or drugs that need treatment.I have had a type of irregular heartbeat called ventricular arrhythmia.You have had a serious reaction to certain medications that affect the brain.You are allergic or have a strong reaction to trazodone or quetiapine.I have not had a heart attack in the last 30 days.I have been diagnosed with dementia.I have been diagnosed with tardive dyskinesia.I was admitted to the ICU with a recent severe brain condition.I have a seizure disorder.I need my medications crushed due to my feeding tube.I have ICU delirium needing medication, confirmed by a CAM-ICU score.I have been diagnosed with Parkinson's disease or parkinsonism.You have a very advanced and serious medical condition.I have been diagnosed with liver disease.I have a long QT interval on my EKG.I have had a recent episode of irregular heart rhythm.You are currently experiencing severe mental health issues that affect your thoughts and behavior.You are not expected to leave the intensive care unit (ICU) within the next 24 hours.I am on medication that interacts with trazodone or quetiapine.I have been in the surgical ICU for more than a day.Low sodium levels in the bloodI am 18 years old or older.You are unable to participate in a test for delirium due to certain medical conditions or disabilities like severe confusion, cognitive impairment, or being deaf or blind.I do not have sudden brain dysfunction due to liver or kidney disease.You have trouble swallowing, have a high risk of food going into your lungs, or have trouble eating or drinking by mouth.
- Group 1: Trazodone
- Group 2: Placebo
- Group 3: Quetiapine
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any volunteers being enrolled in this trial at present?
"Unfortunately, this study has met its recruitment goals and is no longer accepting patients. It was first posted on March 1st 2023 but was last updated on 30th of March 2022. For those searching for other clinical trials, there are currently 412 active studies recruiting participants with mortality concerns and 18 involving the use of trazodone."
Has this experiment been undertaken before?
"Since 2014, Otsuka America Pharmaceutical has conducted 18 distinct drug trials for Trazodone in 157 cities and 27 nations. Moreover, since its inception these studies have involved a total of 18489 individuals. Notably the first experiment was completed at Phase 4 FDA approval stage in that same year with 200 participants."
How many participants have enrolled in this experiment thus far?
"This clinical research has ceased recruitment of participants. Initially listed on March 1st 2023 and last revised on 30th March 2022, the trial is no longer recruiting patients. For those seeking other studies to join, there are 412 trials searching for enrollees regarding mortality as well as 18 studies enrolling people for Trazodone treatment."
In what kind of medical scenarios is the administration of Trazodone beneficial?
"Trazodone is traditionally employed to tackle mental depression, but its efficacy has also been demonstrated in treating dementia, post traumatic stress disorder (PTSD), and eating disorders."
What are the attendant risks associated with Trazodone consumption?
"The safety rating of Trazodone is a 3, which reflects the fact that it has achieved Phase 4 testing and been approved by regulatory bodies."
Are there any previous experiments which have studied Trazodone's efficacy?
"At the current time, 18 clinical trials involving trazodone are actively being conducted. Of these studies, 5 are in their third phase of testing. While most tests take place in Bhubaneswar, Orissa, 473 distinct locations around the world have opened for volunteers to participate and contribute data."
Share this study with friends
Copy Link
Messenger